Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A quick recap of how we got to this point: 2022: Surging GLP-1 demand outpaced
Monthly cuts the number of injections from 52 a year to 12
Participants were randomly assigned to receive either 4, 9, or 12 mg of retatrutide or a placebo for 80 weeks
To find out, contact Womens Health Specialists, PLLC, for a consultation with one of our physicians
The Alleviating Effect and Mechanism of GLP-1 on Ulcerative Colitis
The trial to examine the efficacy of the drug for obesity started with the injection of 0.25mg of semaglutide weekly for the first 4 weeks, with the dose increased every 4 weeks to reach the maintenance dose of 2.4mg weekly by week 16 (lower maintenance doses were permitted if participants had unacceptable side effects with the 2.4mg dose)
